Stereotaxis Inc (STXS) (Q3 2026) Earnings Call Highlights: Revenue Jumps 20% on GenesisX and ...
Stereotaxis Inc (STXS) posted $8.9 million in Q3 2026 revenue and a 60% surge in system sales, yet a $1.9 million catheter backlog and thin cash position cloud the path to profitability. Related Stocks: STXS ,